A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide

DMM Disease Models and Mechanisms

Volumn 6, Issue 6, 2013, Pages 1388-1399

  Williams, Jonathan M ^a   Duckworth, Carrie A ^a   Watson, Alastair J M ^b   Frey, Mark R ^c   Miguel, Jennifer C ^c   Burkitt, Michael D ^a   Sutton, Robert ^d   Hughes, Kevin R ^b,e   Hall, Lindsay J ^b,e   Caamaño, Jorge H ^f   Campbell, Barry J ^a   Pritchard, D Mark ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIPOPOLYSACCHARIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL SURVIVAL; CIRCULATION; CONTROLLED STUDY; DIARRHEA; ENTERITIS; FEMALE; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MOUSE; NONHUMAN; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; SPECIES;

ANIMALS; APOPTOSIS; CASPASE 3; ENZYME ACTIVATION; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPOPOLYSACCHARIDES; MICE; MODELS, ANIMAL; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888862182     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.013284     Document Type: Article

References (44)

1. Abreu, M. T. (2010). Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10, 131-144.
2. Arrieta, M. C., Madsen, K., Doyle, J. and Meddings, J. (2009). Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58, 41-48.
3. Basak, S., Kim, H., Kearns, J. D., Tergaonkar, V., O'Dea, E., Werner, S. L., Benedict, C. A., Ware, C. F., Ghosh, G., Verma, I. M. et al. (2007). A fourth IkappaB protein within the NF-kappaB signaling module. Cell 128, 369-381.
4. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C., Mathison, J., Ulevitch, R. and Cerami, A. (1985). Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552-554.
5. Beutler, B., Du, X. and Poltorak, A. (2001). Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J. Endotoxin Res. 7, 277-280.
6. Bullen, T. F., Forrest, S., Campbell, F., Dodson, A. R., Hershman, M. J., Pritchard, D. M., Turner, J. R., Montrose, M. H. and Watson, A. J. (2006). Characterization of epithelial cell shedding from human small intestine. Lab. Invest. 86, 1052-1063.
7. Caamaño, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventós-Suárez, C., Snapper, C. M. and Bravo, R. (1998). Nuclear factor (NF)-κ B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187, 185-196.
8. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J. and Gusovsky, F. (1999). Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692.
9. Cinel, I., Buyukafsar, K., Cinel, L., Polat, A., Atici, Ş., Tamer, L. and Oral, U. (2002). The role of poly(ADP-ribose) synthetase inhibition in preventing endotoxemiainduced intestinal epithelial apoptosis. Pharmacol. Res. 46, 119-127.
10. Coopersmith, C. M., Stromberg, P. E., Davis, C. G., Dunne, W. M., Amiot, D. M., II, Karl, I. E., Hotchkiss, R. S. and Buchman, T. G. (2003). Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit. Care Med. 31, 1630-1637.
11. Copeland, S., Warren, H. S., Lowry, S. F., Calvano, S. E., Remick, D.; Inflammation and the Host Response to Injury Investigators (2005). Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12, 60-67.
12. Flint, N., Cove, F. L. and Evans, G. S. (1991). A low-temperature method for the isolation of small-intestinal epithelium along the crypt-villus axis. Biochem. J. 280, 331-334.
13. Foster, D. M., Stauffer, S. H., Stone, M. R. and Gookin, J. L. (2012). Proteasome inhibition of pathologic shedding of enterocytes to defend barrier function requires X-linked inhibitor of apoptosis protein and nuclear factor kappaB. Gastroenterology 143, 133-144.e4.
14. Fukushima, H., Matsumoto, A., Inuzuka, H., Zhai, B., Lau, A. W., Wan, L., Gao, D., Shaik, S., Yuan, M., Gygi, S. P. et al. (2012). SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction. Cell Rep 1, 434-443.
15. Gadjeva, M., Wang, Y. and Horwitz, B. H. (2007). NF-kappaB p50 and p65 subunits control intestinal homeostasis. Eur. J. Immunol. 37, 2509-2517.
16. Garside, P., Bunce, C., Tomlinson, R. C., Nichols, B. L. and Mowat, A. M. (1993). Analysis of enteropathy induced by tumour necrosis factor alpha. Cytokine 5, 24-30.
17. Guma, M., Stepniak, D., Shaked, H., Spehlmann, M. E., Shenouda, S., Cheroutre, H., Vicente-Suarez, I., Eckmann, L., Kagnoff, M. F. and Karin, M. (2011). Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation. J. Exp. Med. 208, 1889-1900.
18. Hollander, D., Vadheim, C. M., Brettholz, E., Petersen, G. M., Delahunty, T. and Rotter, J. I. (1986). Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 105, 883-885.
19. Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S. and Richter-Dahlfors, A. (2002). Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195, 559-570.
20. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S. (1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752.
21. Jacque, E., Tchenio, T., Piton, G., Romeo, P.-H. and Baud, V. (2005). RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc. Natl. Acad. Sci. USA 102, 14635-14640.
22. Julian, M. W., Bao, S., Knoell, D. L., Fahy, R. J., Shao, G. and Crouser, E. D. (2011). Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis. Int. J. Exp. Pathol. 92, 366-376.
23. Kawai, T. and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650.
24. Kiesslich, R., Goetz, M., Angus, E. M., Hu, Q., Guan, Y., Potten, C., Allen, T., Neurath, M. F., Shroyer, N. F., Montrose, M. H. et al. (2007). Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 133, 1769-1778.
25. Kiesslich, R., Duckworth, C. A., Moussata, D., Gloeckner, A., Lim, L. G., Goetz, M., Pritchard, D. M., Galle, P. R., Neurath, M. F. and Watson, A. J. (2012). Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61, 1146-1153.
26. Lai, C. W., Sun, T. L., Lo, W., Tang, Z. H., Wu, S., Chang, Y. J., Wu, C. C., Yu, S. C., Dong, C. Y. and Chen, L. W. (2013). Shedding-induced gap formation contributes to gut barrier dysfunction in endotoxemia. J. Trauma Acute Care Surg. 74, 203-213.
27. Lau, K. S., Juchheim, A. M., Cavaliere, K. R., Philips, S. R., Lauffenburger, D. A. and Haigis, K. M. (2011). In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α-induced apoptosis and proliferation by MAPKs. Sci. Signal. 4, ra16.
28. Leblond, C. P. and Stevens, C. E. (1948). The constant renewal of the intestinal epithelium in the albino rat. Anat. Rec. 100, 357-377.
29. Liu, J. J., Madsen, K. L., Boulanger, P., Dieleman, L. A., Meddings, J. and Fedorak, R. N. (2011). Mind the gaps: confocal endomicroscopy showed increased density of small bowel epithelial gaps in inflammatory bowel disease. J. Clin. Gastroenterol. 45, 240-245.
30. Locksley, R. M., Killeen, N. and Lenardo, M. J. (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501.
31. Madara, J. L. (1990). Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J. Membr. Biol. 116, 177-184.
32. McAllister, C. S., Lakhdari, O., Pineton de Chambrun, G., Gareau, M. G., Broquet, A., Lee, G. H., Shenouda, S., Eckmann, L. and Kagnoff, M. F. (2013). TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo. J. Immunol. 190, 418-427.
33. Mizoguchi, E., Mizoguchi, A., Takedatsu, H., Cario, E., de Jong, Y. P., Ooi, C. J., Xavier, R. J., Terhorst, C., Podolsky, D. K. and Bhan, A. K. (2002). Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology 122, 134-144.
34. Pålsson-McDermott, E. M. and O'Neill, L. A. J. (2004). Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113, 153-162.
35. Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B. and Mohler, K. M. (1998). TNF receptordeficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160, 943-952.
36. Pfaffl, M. W., Horgan, G. W. and Dempfle, L. (2002). Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.
37. Piguet, P. F., Vesin, C., Guo, J., Donati, Y. and Barazzone, C. (1998). TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur. J. Immunol. 28, 3499-3505.
38. Potten, C. S. and Loeffler, M. (1990). Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110, 1001-1020.
39. Rodríguez, M., Cabal-Hierro, L., Carcedo, M. T., Iglesias, J. M., Artime, N., Darnay, B. G. and Lazo, P. S. (2011). NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2. J. Biol. Chem. 286, 22814-22824.
40. Schneider, C. A., Rasband, W. S. and Eliceiri, K. W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675.
41. Sha, W. C., Liou, H.-C., Tuomanen, E. I. and Baltimore, D. (1995). Targeted disruption of the p50 subunit of NF-κ B leads to multifocal defects in immune responses. Cell 80, 321-330.
42. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. and Kimoto, M. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
43. Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, A. S., Jr (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
44. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. and Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.